Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder

ClinicalTrials.gov ID: NCT01273376

Public ClinicalTrials.gov record NCT01273376. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether RX-10100 are effective in the treatment of Major Depressive Disorder (MDD).

Study identification

NCT ID
NCT01273376
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Rexahn Pharmaceuticals, Inc.
Industry
Enrollment
314 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2010 (Type not available)
Primary completion
Sep 2011 (Actual)
Completion
Oct 2011 (Actual)
Last update posted
Nov 19, 2013

2010 – 2011

United States locations

U.S. sites
44
U.S. states
20
U.S. cities
41
Facility City State ZIP Site status
Rexahn Investigative Site Cerritos California 90703 —
Rexahn Investigative Site Escondido California 92025 —
Rexahn Investigative Site Los Angeles California 90024 —
Rexahn Investigative Site National City California 91950 —
Rexahn Investigative Site Oceanside California 92056 —
Rexahn Investigative Site Orange California 92868 —
Rexahn Investigative Site San Diego California 92123 —
Rexahn Investigative Site Denver Colorado 82039 —
Rexahn Investigative Site Brooksville Florida 34601 —
Rexahn Investigative Site Gainesville Florida 32607 —
Rexahn Investigative Site Jacksonville Florida 32216 —
Rexahn Investigative Site Miami Beach Florida 33139 —
Rexahn Investigative Site Orlando Florida 32806 —
Rexahn Investigative Site St. Petersburg Florida 33709 —
Rexahn Investigative Site Tampa Florida 33606 —
Rexahn Investigative Site -2 Atlanta Georgia 30328 —
Rexahn Investigative Site Atlanta Georgia 30328 —
Rexahn Investigative Site Oak Brook Illinois 60523 —
Rexahn Investigative Site Vernon Hills Illinois 60061 —
Rexahn Investigative Site Owensboro Kentucky 42301 —
Rexahn Investigative Site Novi Michigan 48377 —
Rexahn Investigative Site Las Vegas Nevada 89146 —
Rexahn Investigative site Cherry Hill New Jersey 08002 —
Rexahn Investigative Site Albuquerque New Mexico 87109 —
Rexahn Investigative Site Fresh Meadows New York 11366 —
Rexahn Investigative Site New York New York 10021 —
Rexahn Investigative Site Cincinnati Ohio 45227 —
Rexahn Investigative site Garfield Heights Ohio 44125 —
Rexahn Investigative Site Oklahoma City Oklahoma 73103 —
Rexahn Investigative site Allentown Pennsylvania 18103 —
Rexahn Investigative Site Media Pennsylvania 19063 —
Rexahn Investigative Site Scranton Pennsylvania 18503 —
Rexahn Investigative Site Anderson South Carolina 29621 —
Rexahn Investigative Site Memphis Tennessee 38119 —
Rexahn Investigative Site Austin Texas 78756 —
Rexahn Investigative site Dallas Texas 75231 —
Rexahn Investigative Site Dallas Texas 75390 —
Rexahn Investigative Sites Lake Jackson Texas 77566 —
Rexahn Investigative Site San Antonio Texas 78229 —
Rexahn Investigative Site The Woodlands Texas 77381 —
Rexahn Investigative Site Orem Utah 84058 —
Rexahn Investigative Site Richmond Virginia 23284 —
Rexahn Investigative Site (2) Bellevue Washington 98007 —
Rexahn Investigative Site Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01273376, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2013 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01273376 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →